MX2022003494A - Azacilos sustituidos como moduladores del miembro 8 de melastatina de potencial receptor transitorio (trmp8). - Google Patents
Azacilos sustituidos como moduladores del miembro 8 de melastatina de potencial receptor transitorio (trmp8).Info
- Publication number
- MX2022003494A MX2022003494A MX2022003494A MX2022003494A MX2022003494A MX 2022003494 A MX2022003494 A MX 2022003494A MX 2022003494 A MX2022003494 A MX 2022003494A MX 2022003494 A MX2022003494 A MX 2022003494A MX 2022003494 A MX2022003494 A MX 2022003494A
- Authority
- MX
- Mexico
- Prior art keywords
- azacyls
- trmp8
- substituted
- transient receptor
- receptor potential
- Prior art date
Links
- 230000001052 transient effect Effects 0.000 title 1
- 102000003610 TRPM8 Human genes 0.000 abstract 1
- 101150111302 Trpm8 gene Proteins 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/24—Thermal properties
- A61K2800/244—Endothermic; Cooling; Cooling sensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Laser Surgery Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019111690 | 2019-10-17 | ||
| PCT/EP2020/079009 WO2021074281A1 (en) | 2019-10-17 | 2020-10-15 | Substituted azacyles as trmp8 modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022003494A true MX2022003494A (es) | 2022-04-25 |
Family
ID=72964655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022003494A MX2022003494A (es) | 2019-10-17 | 2020-10-15 | Azacilos sustituidos como moduladores del miembro 8 de melastatina de potencial receptor transitorio (trmp8). |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12528801B2 (enExample) |
| EP (1) | EP4045491A1 (enExample) |
| JP (1) | JP7778688B2 (enExample) |
| KR (1) | KR20220085798A (enExample) |
| CN (1) | CN114555594B (enExample) |
| BR (1) | BR112022005289A2 (enExample) |
| CO (1) | CO2022004130A2 (enExample) |
| IL (1) | IL292156B2 (enExample) |
| MX (1) | MX2022003494A (enExample) |
| WO (1) | WO2021074281A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202012170D0 (en) * | 2020-08-05 | 2020-09-16 | Givaudan Sa | Organic compounds |
| GB202013383D0 (en) * | 2020-08-26 | 2020-10-07 | Givaudan Sa | Process |
| WO2022170519A1 (en) | 2021-02-09 | 2022-08-18 | Givaudan Sa | Organic compounds |
| GB202102676D0 (en) | 2021-02-25 | 2021-04-14 | Givaudan Sa | Compositions |
| GB202103207D0 (en) | 2021-03-08 | 2021-04-21 | Givaudan Sa | Organic compounds |
| GB202105661D0 (en) | 2021-04-21 | 2021-06-02 | Givaudan Sa | Organic compounds |
| US20240238183A1 (en) | 2021-05-28 | 2024-07-18 | Firmenich Incorporated | Compositions that enhance the cooling effect |
| CN117813077A (zh) * | 2021-08-16 | 2024-04-02 | 西姆莱斯股份公司 | 组合物 |
| US20250387310A1 (en) | 2022-07-07 | 2025-12-25 | Firmenich Incorporated | Compositions that enhance the cooling effect |
| EP4554572A2 (en) | 2022-07-11 | 2025-05-21 | Symrise AG | Mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide |
| JP2026512978A (ja) | 2022-10-27 | 2026-04-22 | フイルメニツヒ ソシエテ アノニム | フラボノイド組成物およびその使用 |
| US20260206810A1 (en) | 2022-12-22 | 2026-07-23 | Firmenich Sa | Natural sweetener compositions and uses thereof |
| US20260206809A1 (en) | 2022-12-22 | 2026-07-23 | Firmenich Sa | Natural sweetener compositions containing alkyl lactates and uses thereof |
| JP2026511252A (ja) | 2023-03-28 | 2026-04-10 | フイルメニツヒ ソシエテ アノニム | 味改変組成物およびその使用 |
| EP4774272A1 (en) | 2023-09-04 | 2026-07-15 | Symrise AG | Trpm8 modulators and related method for modulating trpm8 receptors |
| GB202315636D0 (en) | 2023-10-12 | 2023-11-29 | Givaudan Sa | Composition |
| WO2025132323A1 (en) | 2023-12-21 | 2025-06-26 | Dsm-Firmenich Ag | Compositions comprising a sunscreen active agent |
| WO2026052684A1 (en) | 2024-09-04 | 2026-03-12 | Givaudan Sa | Flavour compositions |
| WO2026087386A1 (en) | 2024-10-24 | 2026-04-30 | Firmenich Sa | Rosin diester compounds and uses thereof |
| WO2026092819A1 (en) | 2024-10-28 | 2026-05-07 | Symrise Ag | Oral care compositions |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3988433A (en) | 1973-08-10 | 1976-10-26 | The Procter & Gamble Company | Oral compositions for preventing or removing stains from teeth |
| US4083955A (en) | 1975-04-02 | 1978-04-11 | The Procter & Gamble Company | Processes and compositions for remineralization of dental enamel |
| US4528180A (en) | 1983-03-01 | 1985-07-09 | Schaeffer Hans A | Dental preparation, article and method for storage and delivery thereof |
| US4849213A (en) | 1983-03-01 | 1989-07-18 | Schaeffer Hans A | Dental preparation, article and method for storage and delivery therof |
| US5198220A (en) | 1989-11-17 | 1993-03-30 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
| US5145666A (en) | 1991-10-23 | 1992-09-08 | The Proctor & Gamble Co. | Methods of reducing plaque and gingivitis with reduced staining |
| US5213790A (en) | 1991-10-23 | 1993-05-25 | The Procter & Gamble Co. | Methods of reducing plaque and gingivitis with reduced staining |
| US5281410A (en) | 1991-10-23 | 1994-01-25 | The Proctor & Gamble Company | Methods of reducing plaque and gingivitis with reduced staining |
| US5242910A (en) | 1992-10-13 | 1993-09-07 | The Procter & Gamble Company | Sustained release compositions for treating periodontal disease |
| US5965537A (en) * | 1997-03-10 | 1999-10-12 | Basf Aktiengesellschaft | Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus |
| AU2479702A (en) * | 2000-10-30 | 2002-05-15 | Janssen Pharmaceutica Nv | Tripeptidyl peptidase inhibitors |
| HUP0500921A2 (en) | 2005-10-05 | 2007-07-30 | Richter Gedeon Nyrt | Tetrazole derivatives, process for their preparation and their use |
| HUP0500920A2 (en) * | 2005-10-05 | 2007-07-30 | Richter Gedeon Nyrt | Oxadiazole derivatives, process for their preparation and their use |
| GB0704163D0 (en) | 2007-03-02 | 2007-04-11 | Quest Int Serv Bv | Compositions comprising a physiological coolant |
| EP2331499B1 (en) * | 2008-08-19 | 2016-09-21 | Janssen Pharmaceutica NV | Cold menthol receptor antagonists |
| AU2009318056B2 (en) | 2008-11-20 | 2014-07-24 | The Procter & Gamble Company | Personal care compositions providing enhanced cooling sensation |
| CN103201279A (zh) | 2010-11-05 | 2013-07-10 | 赛诺米克斯公司 | 作为trpm8的调节剂有用的化合物 |
| WO2014037340A1 (de) | 2012-09-05 | 2014-03-13 | Bayer Cropscience Ag | Verwendung substituierter 2-amidobenzimidazole, 2-amidobenzoxazole und 2-amidobenzothiazole oder deren salze als wirkstoffe gegen abiotischen pflanzenstress |
| CN106103416B (zh) | 2014-03-14 | 2021-03-02 | 拉夸里亚创药株式会社 | 作为trpm8拮抗剂的氮杂螺衍生物 |
| MY195177A (en) * | 2015-06-23 | 2023-01-11 | Kissei Pharmaceutical | Pyrazole Derivative or Pharmaceutically Acceptable Salt Thereof |
| EP3675809B1 (de) | 2017-08-31 | 2023-09-27 | Basf Se | Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe |
| EP3658109B1 (en) | 2017-12-21 | 2022-12-07 | Firmenich SA | Cooling and flavor boosting compositions |
-
2020
- 2020-10-15 IL IL292156A patent/IL292156B2/en unknown
- 2020-10-15 BR BR112022005289A patent/BR112022005289A2/pt unknown
- 2020-10-15 US US17/769,198 patent/US12528801B2/en active Active
- 2020-10-15 CN CN202080072667.6A patent/CN114555594B/zh active Active
- 2020-10-15 EP EP20793607.1A patent/EP4045491A1/en active Pending
- 2020-10-15 MX MX2022003494A patent/MX2022003494A/es unknown
- 2020-10-15 KR KR1020227016597A patent/KR20220085798A/ko active Pending
- 2020-10-15 JP JP2022522773A patent/JP7778688B2/ja active Active
- 2020-10-15 WO PCT/EP2020/079009 patent/WO2021074281A1/en not_active Ceased
-
2022
- 2022-03-31 CO CONC2022/0004130A patent/CO2022004130A2/es unknown
-
2025
- 2025-12-15 US US19/419,870 patent/US20260103459A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7778688B2 (ja) | 2025-12-02 |
| KR20220085798A (ko) | 2022-06-22 |
| US12528801B2 (en) | 2026-01-20 |
| JP2022552401A (ja) | 2022-12-15 |
| US20240132487A1 (en) | 2024-04-25 |
| EP4045491A1 (en) | 2022-08-24 |
| CN114555594A (zh) | 2022-05-27 |
| IL292156A (en) | 2022-06-01 |
| WO2021074281A1 (en) | 2021-04-22 |
| BR112022005289A2 (pt) | 2022-09-20 |
| US20260103459A1 (en) | 2026-04-16 |
| CO2022004130A2 (es) | 2022-07-08 |
| CN114555594B (zh) | 2025-03-18 |
| IL292156B2 (en) | 2026-05-01 |
| IL292156B1 (en) | 2026-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022004130A2 (es) | Azacilos sustituidos como moduladores de trmp8 | |
| CL2020000422A1 (es) | Composiciones de glp-1 y sus usos. | |
| UY38140A (es) | Picolinamidas como fungicidas | |
| DOP2015000054A (es) | Derivados de c17-alcandiilo y alquendiilo del ácido oleanólico y sus métodos de uso | |
| MX2019001096A (es) | Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos. | |
| CO2019006687A2 (es) | Polimorfos | |
| DOP2017000298A (es) | Reguladores de nrf2 | |
| PY2021592A (es) | Arilamidinas fungicidas | |
| DOP2016000145A (es) | Reguladores de nrf2 | |
| CU20190101A7 (es) | Imidazopirimidinas diazabicíclicas sustituidas | |
| CR20160119A (es) | Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística | |
| CO2019006673A2 (es) | Polimorfos | |
| UY36166A (es) | Formas de sales de n—(cianometil)—4—(2—(4—morfolinofenilamino)pirimidin—4—il)benzamida, sus composiciones y su uso terapeutico | |
| ECSP20032718A (es) | Polimorfos | |
| UY34989A (es) | 4-piridonas sustituidas y su uso como inhibidores de la actividad de elastasa de neutrófilos | |
| MX2017002913A (es) | Formas cristalinas de 6-((6,7-dimetoxiquinazolin-4-il)oxi)-n,2-dim etilbenzofuran-3-carboxamida. | |
| BR112022010871A2 (pt) | Composições farmacêuticas oftalmológicas | |
| MX2018009407A (es) | Rapadocinas, inhibidores de transportador 1 de nucleósido equilibrador y sus usos de los mismos. | |
| MX389208B (es) | Composiciones cosméticas para el cuidado de la piel. | |
| CO2020016131A2 (es) | Agonistas de tlr7 | |
| DOP2019000102A (es) | Constructos de vacuna y sus usos contra infecciones causadas por staphylococcus | |
| CO2021017154A2 (es) | Profármacos de moduladores del receptor de nmda campo de la invención | |
| UY38759A (es) | Tienilhidroxiisoxazolinas y derivados de las mismas | |
| CO2019014831A2 (es) | Nuevas formulaciones orales de belinostat | |
| MX2012003693A (es) | Composiciones de olopatadine y usos de las mismas. |